12月19日交易日, 草姬集团股价盘中大涨24.53%,主要受公开发售认购火爆推动。公司公布配发结果,公开发售部分获超额认购约6083倍,是历来港股超额认购第二大新股IPO。一手(800股)中签率仅3%,投资者需申购1250手才可稳获一手。
草姬集团此次全球发售3333.36万股股份,全球发售净筹约9530万港元。公司以招股价下限3.75元定价,是招股范围3.75元至4.15元的下限水平。此外,国际配售部分获1.79倍认购。
资料显示,草姬集团是香港本地保健品及美容护肤品供应商,采用多渠道销售模式,专注于开发和销售自有品牌产品。公司市场覆盖广泛,产品在香港市场占有率领先,市场需求旺盛。这次超高认购反映出资金对公司业务前景和长期增长潜力的看好。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.